Search by Drug Name or NDC

    NDC 65862-0784-30 Esomeprazole Magnesium 40 mg/1 Details

    Esomeprazole Magnesium 40 mg/1

    Esomeprazole Magnesium is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is ESOMEPRAZOLE MAGNESIUM DIHYDRATE.

    Product Information

    NDC 65862-0784
    Product ID 65862-784_46c33c0d-4062-40e0-a599-997488a20240
    Associated GPIs 49270025106540
    GCN Sequence Number 047526
    GCN Sequence Number Description esomeprazole magnesium CAPSULE DR 40 MG ORAL
    HIC3 D4J
    HIC3 Description PROTON-PUMP INHIBITORS
    GCN 12868
    HICL Sequence Number 021607
    HICL Sequence Number Description ESOMEPRAZOLE MAGNESIUM
    Brand/Generic Generic
    Proprietary Name Esomeprazole Magnesium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Esomeprazole Magnesium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name ESOMEPRAZOLE MAGNESIUM DIHYDRATE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205606
    Listing Certified Through 2024-12-31

    Package

    NDC 65862-0784-30 (65862078430)

    NDC Package Code 65862-784-30
    Billing NDC 65862078430
    Package 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-784-30)
    Marketing Start Date 2016-04-21
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.14929
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ESOMEPRAZOLE MAG DR 40 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis